Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs), such as cytotoxic T lymphocyte antigen-4 (CTLA-4) inhibitors, programmed cell death protein 1 (PD-1) inhibitors, and programmed cell death protein 1 ligand 1 (PD-L1) inhibitors, are often used to treat a variety of malignancies. ICIs are known to caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Yuichiro, Kimura, Tomohiko, Iwamoto, Hideyuki, Sanada, Junpei, Fushimi, Yoshiro, Katakura, Yukino, Tatsumi, Fuminori, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899881/
https://www.ncbi.nlm.nih.gov/pubmed/36755909
http://dx.doi.org/10.3389/fendo.2023.1079074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899881/
https://www.ncbi.nlm.nih.gov/pubmed/36755909
http://dx.doi.org/10.3389/fendo.2023.1079074

Ejemplares similares